Patents by Inventor Forrest H. Anthony

Forrest H. Anthony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
    Patent number: 11291644
    Abstract: The described invention provides methods for treating pulmonary cancer in a subject, by administering to the subject by inhalation a composition of inhalational lipid cisplatin (ILC) comprising a lipid-complexed cisplatin.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: April 5, 2022
    Assignee: ELEISON PHARMACEUTICALS, LLC
    Inventors: Forrest H. Anthony, Matthew M. Parris, Edwin J. Thomas, Guangtao Zhang
  • PREVENTING PULMONARY RECURRENCE OF CANCER WITH LIPID-COMPLEXED CISPLATIN
    Publication number: 20140065205
    Abstract: The described invention provides methods for treating pulmonary cancer in a subject, by administering to the subject by inhalation a composition of inhalational lipid cisplatin (ILC) comprising a lipid-complexed cisplatin.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 6, 2014
    Inventors: Forrest H. Anthony, Matthew M. Parris, Edwin J. Thomas, Guangtao Zhang
  • Glufosfamide Combination Therapies for Cancer
    Publication number: 20130281386
    Abstract: The invention provides compositions and methods for treating cancer with glufosfamide in combination with an inhibitor of sodium-glucose transporter type 2 (SGLT2) to block the uptake of glucose in the proximal tubules of the kidneys to decrease renal toxicity. The invention relates to the fields of biomedicine, pharmacology, and molecular biology.
    Type: Application
    Filed: August 30, 2012
    Publication date: October 24, 2013
    Applicant: Eleison Pharmaceuticals LLC
    Inventors: Forrest H. Anthony, Edwin J. Thomas, Matthew Parris